| Fund ID | 805-5829052234 |
| Fund type | Venture Capital Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | No |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| Sales limited to qualified investors | Yes |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 1% |
| Owned by funds of funds | 41% |
| Owned by non-U.S. persons | 19% |
| Fund | Type | Gross assets |
|---|---|---|
| New Leaf Biopharma Opportunities II, L.P. | Venture Capital | $131.9M |
| New Leaf Ventures IV, L.P. | Venture Capital | $118.9M |
| New Leaf Ventures III, L.P. | Venture Capital | $100.5M |
New Leaf Ventures I, L.P. reports $3.9 million in gross assets, among the top 87% of private funds by size.
New Leaf Ventures I, L.P. is managed by New Leaf Venture Partners LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.